Please note the law offices of O’Connor, Acciani & Levy are no longer accepting Reglan injury claims.
The digestive drug Reglan has been linked to tardive dyskinesia, a severe and potentially chronic nervous system disorder that causes repetitive, involuntary movements, such as rapid eye blinking and shaking of the arms and legs. If you suffered tardive dyskinesia or other side effects while taking Reglan, you could be entitled to compensation for the cost of your medical treatment, lost wages, pain and suffering, and other effects of your injuries. The defective drug attorneys at O'Connor, Acciani & Levy are here to help you file your Reglan lawsuit to pursue all of the compensation you are entitled. Our Cincinnati Reglan lawyers can manage every aspect of the legal process, including legal filings, settlement negotiations and courtroom proceedings. At our firm, injury victims are entitled to a free, no obligation legal consultation. We will discuss your legal options and if we think it is in your best interest to pursue a case. If you have grounds for a lawsuit and choose to move forward, we will not charge for our services unless we obtain fair compensation.REGLAN SIDE EFFECTS
The prescription drug Reglan (metoclopramide) has been on the market for more than three decades. It was approved by the U.S. Food and Drug Administration (FDA) to treat a variety of gastrointestinal issues, such as:- Nausea following surgery
- Nausea from chemotherapy
- Acid reflux
- Gastrointestinal reflux disease (GERD)
- Esophageal ulcers
- Heartburn
- Diabetic gastroparesis, which causes the stomach to lose the ability to contract and empty
- Lip smacking
- Grimacing
- Finger movements that resemble movements of someone playing a piano
- Rapid blinking of the eyes
- Puckering the lips
- Sticking out the tongue
- Shaking in the trunk, arms and legs
FDA WARNING
In 2009, the FDA added a black box warning to the labels of medications containing metoclopramide. A black box warning is the most serious warning the FDA adds to drug labels, indicating there is evidence linking the drug to a serious health problem. The warning says the risk of developing TD increases the longer a patient takes Reglan. It says to avoid prescribing Reglan for more than the recommended 12 weeks, except in rare cases when the benefits of the drug outweigh the risks of developing TD. Treatment with this drug should be discontinued when a patient shows signs or symptoms of TD. If you suffered any side effects while taking Reglan, contact our lawyers in Cincinnati to discuss filing a lawsuit to pursue compensation. We understand how devastating TD and other Reglan side effects can be and are committed to fighting for all of the compensation you are entitled.RESEARCH ON REGLAN SIDE EFFECTS
Researchers have warned about the dangers of Reglan for decades. In 1983, the Annals of Internal Medicine published a letter noted that one of the primary concerns about the drug was that prolonged use could cause TD. Almost a decade later, in 1992, the Archives of Family Medicine published a study noting that TD was a serious potential side effect of Reglan. Researchers analyzed 67 case reports on patients who suffered from this disorder. They found the most common location of dyskinetic movements was the face, with 60 percent of patients studied experiencing symptoms in their faces. Follow-up treatment was provided to 21 patients who suffered from TD. Researchers found 15 of the 21 experienced symptoms six months or more after discontinuing Reglan. Another study from 2007 found that many Reglan patients were prescribed this medication for longer than the label recommendations. This study was published in Pharmacoepidemiol Drug Safety. In 2015, the Journal of Mind and Medical Sciences published the results of a questionnaire of 1,000 patients prescribed Reglan in Bucharest. The questionnaire revealed that certain factors could increase the likelihood of neurological side effects. For example, 18 of the patients who reported moderate to severe side effects were on other medications:- Five patients were taking selective serotonin inhibitors and suffered hyperthermia, intense sweating and agitation when they began taking Reglan
- Seven patients taking first generation antihistaminic drugs suffered intense daytime sleepiness and poor motor coordination
- Four patients were taking antidopaminergic neuroleptics and suffered involuntary movements in the neck and tongue muscles, rigidity in their extremities, hyperthermia and hallucinations
- Two patients with epilepsy who were already taking carbamazepine suffered epileptic seizures more intense than usual within 12 to 36 hours of starting Reglan